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Rapid sequence intubation (RSI) is a technique in which an induction agent and neuromuscular 
blocker are administered simultaneously to quickly enable mechanical ventilation. Compared to 
other methods of intubation, RSI has a higher first attempt success rate and minimizes 
complications such as prolonged hypoxemia and aspiration. Etomidate has frequently been 
cited as the gold standard for RSI induction. However, recent drug shortages and potential 
associations with adrenal axis suppression have renewed interests in alternative induction 
agents for RSI. 
Ketamine can be used for induction and has also been used as an alternative agent in pediatric 
patients, those undergoing trauma, or in the hemodynamically unstable. Through a 
catecholamine response, ketamine can increase cardiac output, heart rate, and blood pressure 
giving it a favorable hemodynamic profile. With negligible effect on the adrenal axis, ketamine 
can be used as an alternative to etomidate in patients with adrenal deficiency. However, there 
is some evidence to suggest that in a catecholamine depleted patient, ketamine may have the 
opposite effect on them. This occurs through a negative inotropic and chronotropic effect. 
It is important for clinicians to understand a drug’s safety profile and how it might affect the 
patient during RSI so they can prepare accordingly. The objective of this study aims to evaluate 
the safety of ketamine versus etomidate in a community hospital emergency room setting. 
• Compare the safety of ketamine versus etomidate in patients undergoing RSI in 
the emergency department
• Highlight role of ketamine in RSI in a community hospital
A comparison of the safety of ketamine versus etomidate in rapid sequence intubation in the community hospital emergency department setting
•Single center, retrospective chart review 
•January 2017-December 2020Study Design
•> 18 years old
•Ketamine or etomidate for induction during RSI








Background Objectives and Purpose
Outcomes
• Composite outcome of ketamine versus etomidate 
including incidence of hypertension, hypotension, 
tachycardia, or hypoxia after intubation
Primary
• Percentage of successful first pass intubation 
• Additional ketamine or etomidate required
• Ketamine and etomidate dose appropriateness 
• Vasopressor requirements
• Witnessed aspiration during intubation
Secondary
Baseline Characteristics
Characteristics (Mean) Ketamine (N = 100) Etomidate (N=100)
Age (Years) 62 70
Weight (kg) 87 83
MAP (mmHg) 89 87
SpO2 89 92






HR (95% CI) P-Value
Composite: 15.5 23.8 0.77 (0.51-1.17) 0.22
Hypertension 9 9 1.0 (0.62-1.62) 1.0
Hypotension 9 31 0.45 (0.25-0.81) 0.008
Tachycardia 33 42 0.88 (0.66-1.18) 0.39






RR/HR (95% CI) P-Value
Successful 1st Pass 91 90 1.01 (0.82-1.23) 0.96
Additional Doses Given 3 0 2.0 (1.74-2.30) < 0.0001
Dose Appropriateness 74 78 0.97 (0.79-1.21) 0.81
Vasopressor after 
Intubation
39 51 0.87 (0.66-1.40) 0.31
Witnessed Aspiration 8 7 1.07 (0.65-1.75) 0.80
Mortality 13 28 0.63 (0.40-1.01) 0.058
